CTOs on the Move

GlobeImmune

www.globeimmune.com

 
GlobeImmune is a Louisville, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Access Biologicals

Access Biologicals is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avalanche Biotech

Avalanche is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases. Using a next generation gene therapy platform, the Ocular BioFactory™, the Company is developing products designed to provide long-term benefit or a functional cure by inducing a sustained expression of a therapeutic protein with a one-time administration in the eye.

Aquatic Biotechnologies Inc

Aquatic Biotechnologies Inc is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brain Cells

Brain Cells is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ironwood Pharmaceuticals

Ironwood is committed to the art and science of making medicines. Patient needs shape our business. They inform our drugmaking process. We rely on patients to help us understand and address those unmet needs. Whether we’re transforming knowledge into medicine or tackling the equally challenging task of delivering that medicine to people around the world, patients inspire us. Shareholders shape our success. Being a shareholder of Ironwood is about more than owning our shares, it's about being an owner of our business. We hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company. Employees shape our future. At Ironwood, we’re building a team of talented individuals who embrace the incredibly challenging task of making medicines. All our employees are equity holders, which means we are careful stewards of our resources, and we share the responsibility to build and grow this company. Our discovery and development processes have generated a product that’s approved in the United States, the European Union and a number of other countries, as well as a robust pipeline. We hope to continue earning the right to make medicines and, one step at a time, build an enduring pharmaceutical company that helps patients lead better lives.